S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

MIRM Mirum Pharmaceuticals Inc

44.00

-0.64 (-1.43%)

Mar 06 2025 - Closed

Delayed by 15 minutes

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Mirum Pharmaceuticals (NASDAQ:MIRM)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Mirum Pharmaceuticals Charts.

Mirum Pharmaceuticals (NASDAQ:MIRM)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Mirum Pharmaceuticals Charts.

Mirum Pharmaceuticals Inc News

Form S-8 - Securities to be offered to employees in employee benefit plans
Wednesday 26 February 2025 (1 week ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Wednesday 26 February 2025 (1 week ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 26 February 2025 (1 week ago) • Edgar (US Regulatory)

Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update
Wednesday 26 February 2025 (1 week ago) • Business Wire

Mirum’s CTEXLI™ (chenodiol) Tablets Receives FDA Approval for Treatment of Cerebrotendinous Xanthomatosis (CTX)
Monday 24 February 2025 (2 weeks ago) • Business Wire

Mirum Pharmaceuticals to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call on February 26, 2025
Wednesday 19 February 2025 (2 weeks ago) • Business Wire

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Monday 10 February 2025 (3 weeks ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 4 February 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 27 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 23 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 13 January 2025 (2 months ago) • Edgar (US Regulatory)

Mirum Pharmaceuticals Announces Preliminary Unaudited 2024 Net Product Sales and Cash Balance and Provides Corporate Updates
Monday 13 January 2025 (2 months ago) • Business Wire

More Mirum Pharmaceuticals Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions